期刊文献+

真实世界中老年非小细胞肺癌的临床特征及预后分析 被引量:10

Clinical features and prognostic factors of elderly non-small cell lung cancer patients in real-life clinical practice
下载PDF
导出
摘要 目的:探讨真实世界中老年非小细胞肺癌患者的临床特点及预后因素。方法:回顾性分析我院肿瘤科、胸外科、呼吸科及老年病科2015年6月至2017年6月出院的老年非小细胞肺癌患者的临床资料742例,利用SPSS 17. 0软件进行统计学处理,K-M法进行单因素分析,Log-rank法评价生存差异,COX多因素回归模型对多个变量分析确定影响预后的因素,检验水准为α=0. 05,分别探讨了性别、年龄、体能状态(ECOG)、临床分期、病理类型、合并症、治疗方式等7个因素对预后的影响。结果:我中心老年非小细胞肺癌男女性别比例为3. 7∶1,单因素分析显示年龄、病理类型、ECOG评分、临床分期、治疗方式及合并症是影响预后的危险因素,多因素分析显示病理类型、ECOG评分、临床分期、治疗方式及合并症是影响预后的独立危险因素。结论:我中心老年非小细胞肺癌患者男女比例稍高,性别、年龄对生存期无显著影响,而病理为腺鳞癌、ECOG评分高、临床分期晚、合并症多及姑息治疗方式是预后不佳的独立危险因素。 Objective:To explore the clinical features and prognostic factors of elderly patients with non-small cell lung cancer in real-life.Methods:The clinical data of 742 patients with non-small cell lung cancer(NSCLC)who were discharged from our hospital from June 2015 to June 2017,including Oncology,Thoracic Surgery,Respiratory Department and Geriatric Department,were retrospectively analyzed.SPSS 17.0 software was used to carry out statistical analysis with K-M method and Log-rank method was used to evaluate survival difference.COX multivariate regression model was used to determine the prognostic factors of multiple variables.The test level wasα=0.05.Gender,age,physical condition(ECOG),clinical stage,pathological type,complication and treatment were studied respectively.Results:The gender ratio of male and female in elderly non-small cell lung cancer in our center was 3.7∶1.Univariate analysis showed that age,pathological type,ECOG,clinical stage,treatment style and complications were risk factors for prognosis,and multivariate analysis showed pathological type,ECOG,clinical stage,treatment style and complications were risk factors for prognosis.Conclusion:The male and female ratio of elderly patients with NSCLC in our center is slightly higher than that of young patients.Gender and age have no significant influence on survival,but adenosquamous carcinoma,high ECOG score,late clinical staging,multiple complications and palliative treatment are independent risk factors for poor prognosis.
作者 张一卓 张文霞 王丽娟 韦红 朱启峰 Zhang Yizhuo;Zhang Wenxia;Wang Lijuan;Wei Hong;Zhu Qifeng(Department of Geriatrics,Heze Municiple Hospital,Shandong Heze 274000,China;Department of Oncology,Heze Municiple Hospital,Shandong Heze 274000,China)
出处 《现代肿瘤医学》 CAS 2019年第3期415-419,共5页 Journal of Modern Oncology
基金 山东省医药卫生科技发展计划(保健)项目(编号:2015WSCO2042)
关键词 肺肿瘤 老年病 预后 lung neoplasms geriatrics prognosis
  • 相关文献

参考文献13

二级参考文献136

  • 1王晓华,马大庆,陈卉.毛刺征在CT诊断周围型小肺癌中的价值[J].中国医学影像学杂志,2006,14(2):127-130. 被引量:55
  • 2王洪武.晚期肺癌患者的多学科微创综合治疗现状[J].中华结核和呼吸杂志,2006,29(3):198-199. 被引量:6
  • 3肖高明,陈跃军,周石林,谭正,梁剑平.肺腺鳞癌根治术48例分析[J].湖南医学,1996,13(2):86-87. 被引量:1
  • 4-.王德延肿瘤病理诊断学,第二版[M].天津:天津科学技术出版社,1999.586.
  • 5Wingo PA, Cardinez CJ, Landis SH, et al. Long-term trends in cancer mortal- ity in the United States, 1930-1998. Cancer, 2003, 97( 12 Suppl): 3133-3275.
  • 6Gridelli C. Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer? Lung Cancer, 2002, 38 (Suppl 2): S45-S50.
  • 7中国抗癌协会肺癌专业委员会编著.2010中国肺癌临床指南.第1版.北京:人民卫生出版社,2010.7.
  • 8Meriggi F, Zaniboni A. Non-small-cell lung cancer in the elderly. Crit Rev Oncol Hematol, 2006, 57(2): 183-190.
  • 9Langer CJ, Manola J, Bernardo P, et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Nail Cancer Inst, 2002, 94(3): 173-181.
  • 10Wakelee HA, Wang W, Schiller JH, et al. Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594. J Thorac Oncol, 2006, 1 (S): 441-446.

共引文献118

同被引文献108

引证文献10

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部